Ukraine trade group meets with Deputy Health Minister over burning issues in healthcare sector

8 February 2016

Ukraine’s Association of Pharmaceutical Research and Development (APRaD) representatives recently took part in a meeting with Igor Perehinets, Deputy Minister of Health of Ukraine devoted to the health care reform and public procurements in the health care sector.

During the meeting all participants had an opportunity to clarify the most sensitive issues directly with the MoH Deputy. The event was organized and held by the American Chamber of Commerce in Ukraine.

The discussion was opened by Andy Hunder, Chamber president, highlighted that dialog between government and business is vital for success of reforms since it creates the necessary synergy for the next step of Ukrainian quality and accessible healthcare system.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK